Innovative Gene Therapy Lowers Eye Pressure in Mice as a Reversible Alternative to Glaucoma Drops
A groundbreaking gene therapy using CRISPR-Cas13d effectively reduces eye pressure in mice, providing a reversible and potentially less invasive alternative to daily glaucoma eye drops.
Recent advances in gene editing have demonstrated promising results in managing intraocular pressure (IOP), a key factor in glaucoma development. Researchers utilized the CRISPR-based effectors, specifically Cas13d, to target and downregulate two genes—AQP1 and CA2—that are integral to aqueous humor production within the ciliary bodies of mouse eyes. This innovative approach led to a significant reduction in eye pressure: treated mice experienced a decrease of approximately 2.5 mmHg and 1.7 mmHg in IOP, compared to control groups. Importantly, this method does not permanently alter the DNA, making it a reversible and adjustable treatment option. The study, published in PNAS Nexus, indicates that such gene therapy could be adapted for human use, requiring only monthly or less frequent administrations. While further research is necessary to optimize timing, dosage, and delivery methods, this technique offers a potential paradigm shift in glaucoma management, reducing reliance on daily eye drops that can cause adverse effects and are often poorly adhered to by patients.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Computational Model Enhances Blood Flow Analysis in Brain Aneurysms
A new computational approach combines 4D MRI, CFD, and data assimilation to accurately analyze blood flow in brain aneurysms, reducing computational costs and improving clinical assessment.
Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors
Severe COVID-19 survivors may experience prolonged cardiac microvascular dysfunction, impacting blood flow and heart function. New research underscores the importance of understanding these lasting effects for better treatment options.
Elevated BMI Levels Increase Risk of Post-Bariatric Surgery Complications
Higher body mass index (BMI), especially over 50, significantly raises the risk of complications after bariatric surgery, according to recent research. This study provides crucial insights for improving patient safety and outcomes.
Pregnancy Exposure to Fine Particulate Matter Might Elevate Childhood Obesity Risk
A large European study links prenatal exposure to fine particulate matter (PM2.5) with a higher risk of childhood overweight and obesity, especially during ages 9 to 12. The research highlights pregnancy as a critical period of vulnerability to air pollution's long-term health effects.